139 related articles for article (PubMed ID: 23161429)
1. Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C.
Kohjima M; Enjoji M; Yoshimoto T; Yada R; Fujino T; Aoyagi Y; Fukushima N; Fukuizumi K; Harada N; Yada M; Kato M; Kotoh K; Nakashima M; Sakamoto N; Tanaka Y; Nakamuta M
J Med Virol; 2013 Feb; 85(2):250-60. PubMed ID: 23161429
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
3. Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1.
Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2012 Jul; 84(7):1097-105. PubMed ID: 22585728
[TBL] [Abstract][Full Text] [Related]
4. Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: a multicenter study.
Toyoda H; Kumada T; Shimada N; Takaguchi K; Ide T; Sata M; Ginba H; Matsuyama K; Izumi N
J Med Virol; 2013 Jan; 85(1):65-70. PubMed ID: 23154876
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis C.
Hara T; Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Kumada H
J Med Virol; 2013 Oct; 85(10):1746-53. PubMed ID: 23861088
[TBL] [Abstract][Full Text] [Related]
6. An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin.
Kondo C; Atsukawa M; Tsubota A; Itokawa N; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Sakamoto C
J Viral Hepat; 2012 Sep; 19(9):615-22. PubMed ID: 22863265
[TBL] [Abstract][Full Text] [Related]
7. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus.
Berenguer J; von Wichmann MA; Quereda C; Miralles P; Mallolas J; López-Aldeguer J; Alvarez-Pellicer J; De Miguel J; Crespo M; Guardiola JM; Tellez MJ; Galindo MJ; Arponen S; Barquilla E; Bellón JM; González-García J;
J Antimicrob Chemother; 2011 Dec; 66(12):2843-9. PubMed ID: 21965432
[TBL] [Abstract][Full Text] [Related]
8. Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy.
Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2012 Oct; 84(10):1593-9. PubMed ID: 22930507
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.
Farag RE; Arafa MM; El-Etreby S; Saudy NS; Eldeek BS; El-Alfy HA; Goda IF; Ali RM
Arch Iran Med; 2013 Feb; 16(2):68-73. PubMed ID: 23360626
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b.
Toyoda H; Kumada T; Tada T; Hayashi K; Honda T; Katano Y; Goto H; Kawaguchi T; Murakami Y; Matsuda F
J Med Virol; 2012 Jan; 84(1):61-70. PubMed ID: 22095536
[TBL] [Abstract][Full Text] [Related]
11. Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C.
Moreno J; Moraleda G; Barcena R; Mateos M; del Campo S
World J Gastroenterol; 2004 Jan; 10(1):143-6. PubMed ID: 14695786
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of Sjögren syndrome associated with hepatitis C virus when chronic hepatitis C is treated by interferon or the association of interferon and ribavirin].
Doffoël-Hantz V; Loustaud-Ratti V; Ramos-Casals M; Alain S; Bezanahary H; Liozon E; Fauchais AL; Vidal E
Rev Med Interne; 2005 Feb; 26(2):88-94. PubMed ID: 15710254
[TBL] [Abstract][Full Text] [Related]
13. Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy.
Hsu CS; Hsu SJ; Liu WL; Chen DS; Kao JH
Sci Rep; 2016 Aug; 6():32303. PubMed ID: 27561198
[TBL] [Abstract][Full Text] [Related]
14. Associations between responses to interferon therapy and genetic variation in interleukin-28B and the core region of hepatitis C virus genotype 3a.
Yamada K; Ishigami M; Kuzuya T; Honda T; Hayashi K; Goto H
J Med Virol; 2015 Aug; 87(8):1361-7. PubMed ID: 25907669
[TBL] [Abstract][Full Text] [Related]
15. Extended treatment duration for treatment naïve chronic hepatitis C genotype 1 late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of pegylated interferon and ribavirin.
Parikh M; Singh A; Sood G
J Viral Hepat; 2011 Apr; 18(4):e99-103. PubMed ID: 20950407
[TBL] [Abstract][Full Text] [Related]
16. [Natural human IFNβ and ribavirin combination therapy].
Joshita S; Tanaka E
Nihon Rinsho; 2015 Feb; 73(2):273-9. PubMed ID: 25764682
[TBL] [Abstract][Full Text] [Related]
17. Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin.
Banerjee S; Keval R; Gakkhar S
Math Biosci; 2013 Oct; 245(2):235-48. PubMed ID: 23891586
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein profiles and response to pegylated interferon plus ribavirin combination therapy in patients with chronic HCV genotype 1b infection.
Aizawa Y; Shimada N; Abe H; Seki N; Aida Y; Ishiguro H; Ika M; Kato K; Tsubota A
Hepat Mon; 2013 May; 13(5):e8988. PubMed ID: 23967025
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment.
Neukam K; Mira JA; Gilabert I; Claro E; Vázquez MJ; Cifuentes C; García-Rey S; Merchante N; Almeida C; Macías J; Pineda JA
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1225-32. PubMed ID: 21971821
[TBL] [Abstract][Full Text] [Related]
20. Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C.
Vigani AG; Pavan MH; Tozzo R; Gonçales ES; Lazarini MS; Oliveira AM; Gonçales FL
Braz J Infect Dis; 2010; 14(2):193-6. PubMed ID: 20563450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
